RG
AZN icon

Rikoon Group’s AstraZeneca AZN Stock Holding History

Rikoon Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$1.15M Sell
11,563
-350
-3% -$35.2K 0.31% 78
2020
Q4 		$1.19M Sell
11,913
-730
-6% -$77.3K 0.33% 67
2020
Q3 		$1.39M Sell
12,643
-125
-1% -$13.9K 0.43% 54
2020
Q2 		$1.35M Sell
12,768
-450
-3% -$46.5K 0.45% 51
2020
Q1 		$1.18M Sell
13,218
-225
-2% -$21.2K 0.49% 50
2019
Q4 		$1.34M Sell
13,443
-410
-3% -$38.6K 0.46% 55
2019
Q3 		$1.24M Hold
13,853
– – 0.46% 54
2019
Q2 		$1.14M Hold
13,853
– – 0.43% 62
2019
Q1 		$1.12M Sell
13,853
-884
-6% -$69.7K 0.42% 68
2018
Q4 		$1.12M Sell
14,737
-1,150
-7% -$89.8K 0.46% 58
2018
Q3 		$1.26M Sell
15,887
-1,020
-6% -$77.1K 0.45% 57
2018
Q2 		$1.19M Sell
16,907
-606
-3% -$43.6K 0.45% 59
2018
Q1 		$1.22M Buy
17,513
+38
+0.2% +$2.63K 0.49% 51
2017
Q4 		$1.21M Sell
17,475
-275
-2% -$18.5K 0.5% 57
2017
Q3 		$1.2M Sell
17,750
-140
-0.8% -$8.85K 0.52% 53
2017
Q2 		$1.22M Buy
17,890
+225
+1% +$14.7K 0.54% 53
2017
Q1 		$1.07M Sell
17,665
-840
-5% -$48.9K 0.47% 59
2016
Q4 		$1.09M Buy
18,505
+115
+0.6% +$6.53K 0.48% 59
2016
Q3 		$1.21M Buy
+18,390
New +$1.2M 0.96% 36

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rikoon Group's AZN Position: Q1 2021 in Review

Rikoon Group reduced its AstraZeneca (AZN) stake by 2.9% in Q1 2021, selling an estimated $35.2K and leaving 11,563 shares worth $1.15M. The position accounts for 0.31% of the portfolio, ranked #78.

Rikoon Group first reported a position in AZN in Q3 2016 and has held it in 19 quarters since. The position peaked at $1.39M in Q3 2020. 756 funds tracked by Wall St. Rank hold AZN as of Q1 2021.

  • Rikoon Group held 11,563 shares of AstraZeneca worth $1.15M as of Q1 2021.
  • Rikoon Group sold 350 AstraZeneca shares in Q1 2021, an estimated $35.2K.
  • AstraZeneca made up 0.31% of Rikoon Group's portfolio in Q1 2021, its #78 holding.
  • Rikoon Group first reported a position in AstraZeneca in Q3 2016 and has held it in 19 quarters since.
  • Rikoon Group's AstraZeneca position peaked at $1.39M in Q3 2020.
  • 756 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.